Icecure Medical (ICCM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.39M
Last updated: Nov 17, 2026 at 4:37 PM ET
Icecure Medical (ICCM) Statistics
Icecure Medical (ICCM) has a market cap of $3.39M. It kept -427.67% of revenue as net income over the last 12 months. Revenue grew 41.62% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $3.39M |
|---|---|
| Latest price (Nov 17, 2026) | $0.83 |
Key Dates
The next earnings report is set for Nov 18, 2026, before the open.
| Next Earnings Date | Nov 18, 2026, before the open |
|---|---|
| Last Earnings Date | Aug 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.6x and 0.2x. Its year-end P/S ranged from 11.7x to 24.2x from 2022 to 2025.
| P/S Ratio | 0.6x |
|---|---|
| Forward P/S | 0.8x |
| P/B Ratio | 0.2x |
Price Statistics
The stock is down 96.12% over 52 weeks and trades 35.66% below its 50-day average.
| Beta (1Y) | 1.20 |
|---|---|
| 52-Week Change | -96.12% |
| 1-Month Change | -23.14% |
| 3-Month Change | -67.06% |
| 6-Month Change | -87.86% |
| 5-Year Change | -99.60% |
| 10-Year Change | -85.51% |
| Total Return (1Y) | -96.12% |
| Total Return (3Y CAGR) | -66.55% |
| Total Return (5Y CAGR) | -66.17% |
| Max Drawdown (1Y) | -96.89% |
| Max Drawdown (3Y) | -98.54% |
| Sharpe Ratio (1Y) | -2.02 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $1.29 |
| 200-Day Average | $6.81 |
| 52-Week Range | $0.65 to $22.50 |
| RSI (14 Days) | 39.3 |
| Average Volume (20 Days) | 126.37K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.87x current liabilities.
| Current Ratio | 2.87x |
|---|---|
| Quick Ratio | 2.44x |
| Interest Coverage | -106.52x |
Returns and Efficiency
Return on equity is -141.90% and return on assets is -95.33% over the last 12 months.
| Return on Equity (ROE) | -141.90% |
|---|---|
| Return on Assets (ROA) | -95.33% |
| Return on Capital Employed (ROCE) | -140.33% |
| ROA (5Y Average) | -81.28% |
| Asset Turnover | 0.28x |
| Inventory Turnover | 0.97x |
| Receivables Turnover | 11.49x |
| Cash Conversion Cycle | 218 days |
Scores
ICCM has an Altman Z-Score of -12.11, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -12.11 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $3.95M over the last 12 months.
| Revenue | $3.95M |
|---|---|
| Revenue Growth (YoY) | +41.62% |
| Gross Profit | $1.43M |
| Operating Income | -$21.96M |
| Pretax Income | -$16.88M |
| Net Income | -$16.88M |
| EBITDA | -$16.44M |
| EBIT | -$16.72M |
| Reported EPS (TTM) | -$6.77 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 67.19% of the $17.71M in total assets.
| Cash and Equivalents | $12.03M |
|---|---|
| Working Capital | $10.86M |
| Shareholder Equity | $11.90M |
| Book Value Per Share | $3.85 |
| Total Assets | $17.71M |
| Total Liabilities | $5.81M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $69.77K of capital spending, operating cash flow left -$16.39M of free cash flow.
| Operating Cash Flow | -$16.32M |
|---|---|
| Capital Expenditures | $69.77K |
| Free Cash Flow | -$16.39M |
| FCF Per Share | -$3.53 |
| Depreciation and Amortization | $284.00K |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -556.35%.
| Gross Margin | 36.10% |
|---|---|
| Operating Margin | -556.35% |
| Pretax Margin | -427.67% |
| Net Margin | -427.67% |
| EBITDA Margin | -416.49% |
| EBIT Margin | -423.69% |
| FCF Margin | -415.23% |
| Gross Margin (5Y Average) | 44.10% |
Growth
Revenue grew 3.08% a year over 3 years.
| Revenue Growth (3Y CAGR) | +3.08% |
|---|---|
| Revenue Growth (5Y CAGR) | -2.67% |
Dividends and Yields
ICCM does not pay a dividend. Its free cash flow yield is -639.62%.
| FCF Yield | -639.62% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-30 reverse split on Jun 4, 2026.
| Last Split Date | Jun 4, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Peer Position
Against 7 similar companies, ICCM has the 4th highest P/S.
P/S RatioPeer median 0.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +36.55%
| P/S Ratio | 0.6x vs 0.6x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +41.62% vs +36.55% median |
Analyst Forecast
Consensus estimates put revenue growth at 61.41% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +61.41% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ICCM
What is ICCM's market cap?
Icecure Medical has a market cap of $3.39M.
How many shares of ICCM are outstanding?
Icecure Medical has 3.09M shares outstanding.
Does ICCM pay a dividend?
No. Icecure Medical does not pay a dividend.
ICCM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors